<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00973700</url>
  </required_header>
  <id_info>
    <org_study_id>V112_04</org_study_id>
    <nct_id>NCT00973700</nct_id>
  </id_info>
  <brief_title>Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years)</brief_title>
  <official_title>A Randomized, Open Label, Single Center, Dose- and Regimen-Ranging Study to Evaluate Immunogenicity, Safety and Tolerability of Different Formulations of an Adjuvanted and Non-Adjuvanted Egg-Derived, Inactivated Novel Swine Origin A/H1N1 Monovalent Subunit Influenza Virus Vaccine in Healthy Children and Adults Ages 3 to 64 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novartis Vaccines</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novartis</source>
  <brief_summary>
    <textblock>
      This study will evaluate the safety and immunogenicity of different combinations of A/H1N1
      S-OIV (swine flu) vaccine in healthy young children, adolescents, and adults.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Subjects With Seroconversion and HI Titer ≥1:40 in Children 3 to 17 Years of Age</measure>
    <time_frame>Day 1 to day 387</time_frame>
    <description>Seroconversion: The percentage of subjects with either a pre-vaccination HI titer &lt; 1:10 and a post-vaccination HI titer &gt;1:40 or a prevaccination HI titer &gt;1:10 and a minimum four-fold rise in post-vaccination HI antibody titer.
The analyses were performed on the Per-Protocol Set (PPS).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Subjects With Seroconversion and HI Titer ≥ 1:40 in Adults 18 to 64 Years of Age</measure>
    <time_frame>Day 1 to day 387</time_frame>
    <description>Seroconversion: The percentage of subjects with either a pre-vaccination HI titer &lt; 1:10 and a post-vaccination HI titer &gt;1:40 or a prevaccination HI titer &gt;1:10 and a minimum four-fold rise in post-vaccination HI antibody titer.
Analyses were performed on the Per-Protocol set (PPS).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Age Distribution at Baseline</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Subjects With Seroconversion and HI Titer ≥1:40, in 3 to &lt;9 Years and 9 to 17 Years</measure>
    <time_frame>Day 1 to day 387</time_frame>
    <description>Seroconversion: The percentage of subjects with either a pre-vaccination HI titer &lt; 1:10 and a post-vaccination HI titer &gt;1:40 or a prevaccination HI titer &gt;1:10 and a minimum four-fold rise in post-vaccination HI antibody titer.
The analyses were performed on the Per-Protocol Set (PPS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HI GMRs, in 3 to &lt;9 Years and 9 to 17 Years</measure>
    <time_frame>Day 1 to day 387</time_frame>
    <description>Geometric Mean Ratios (GMRs) of hemagglutination inhibition (HI) antibody assay (ratio of post-vaccination versus pre-vaccination HI titers).
The analyses were performed on the the per-protocol set (PPS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HI GMR, in Adults 18 to 64 Years</measure>
    <time_frame>Day 1 to day 387</time_frame>
    <description>Geometric Mean Ratios (GMRs) of hemagglutination inhibition (HI) antibody assay (ratio of post-vaccination versus pre-vaccination HI titers).
The analyses were performed on the Per-Protocol Set (PPS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Subjects With Seroconversion and HI Titer ≥1:40, in Adults 18 to 64 Years</measure>
    <time_frame>7 days and 21 days after each vaccination</time_frame>
    <description>Seroconversion: The percentage of subjects with either a pre-vaccination HI titer &lt; 1:10 and a post-vaccination HI titer &gt;1:40 or a prevaccination HI titer &gt;1:10 and a minimum four-fold rise in post-vaccination HI antibody titer.
The analyses were performed on the per-protocol set (PPS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects With at Least One Reactogenicity Sign, in 3 to &lt;9 Years of Age</measure>
    <time_frame>7 days after each vaccination</time_frame>
    <description>Number of subjects with specified solicited local and systemic reactions in adult subjects (3 to &lt;9 years of age).
Postvac: postvaccination; Analges: analgesics; Antipyr: antipyretics. The analyses were performed on the safety set. Note: 1) postvac 1 = after the first vaccination and 2) postvac 2 = after the second vaccination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects With at Least One Reactogenicity Sign, in 9 to 17 Years of Age</measure>
    <time_frame>7 days after each vaccination</time_frame>
    <description>Number of subjects with specified solicited local and systemic reactions in adult subjects (9 to 17 years of age).
Postvac: postvaccination Analges: analgesics Antipyr: antipyretics The analyses were performed on the safety set.
Note: 1) postvac 1 = after the first vaccination and 2) postvac 2 = after the second vaccination.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects With at Least One Reactogenicity Sign, in 18 to 64 Years of Age</measure>
    <time_frame>7 days after each vaccination</time_frame>
    <description>Number of subjects with specified solicited local and systemic reactions in adult subjects (18 to 64 years of age).
Note: 1) postvac. 1 = after the first vaccination and 2) postvac. 2 = after the second vaccination.
The analyses were performed on the safety set.</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">784</enrollment>
  <condition>Novel 2009 Influenza H1N1</condition>
  <arm_group>
    <arm_group_label>2x7.5adj</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two doses of MF59 adjuvanted (adj) A/H1N1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>7.5adj_1_8</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MF59 adjuvanted (adj) A/H1N1 on days 1 and 8</description>
  </arm_group>
  <arm_group>
    <arm_group_label>7.5adj_1_22</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MF59 adjuvanted (adj) A/H1N1 on study days 1 and 22</description>
  </arm_group>
  <arm_group>
    <arm_group_label>15_1_22</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A/H1N1 on study days 1 and 22</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2x15_1_22</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two doses of A/H1N1 (one in each arm) on study days 1 and 22</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>MF59-eH1N1_f</intervention_name>
    <description>MF59 adjuvanted (adj) egg-derived A/H1N1 with traces of Thiomersal</description>
    <arm_group_label>2x7.5adj</arm_group_label>
    <arm_group_label>7.5adj_1_8</arm_group_label>
    <arm_group_label>7.5adj_1_22</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>eH1N1_f</intervention_name>
    <description>Unadjuvanted egg-derived A/H1N1 with traces of Thiomersal</description>
    <arm_group_label>15_1_22</arm_group_label>
    <arm_group_label>2x15_1_22</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children, adolescents, and adults 3 to 64 years of age in good health as determined by
             medical history, physical assessment and clinical judgement of the investigator and
             without influenza within the past 6 months.

        Exclusion Criteria:

          -  History of serious disease.

          -  History of serious reaction following administration of vaccine or hypersensitivity to
             vaccine components.

          -  Known or suspected impairment/alteration of immune function.

          -  Receipt or planned receipt of seasonal trivalent influenza vaccine within 1 week
             before or after each study vaccination.

        For additional entry criteria, please refer to protocol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Novartis Vaccines</last_name>
    <role>Study Director</role>
    <affiliation>Novartis Vaccines</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto de Atencion Pediatrica, Avenida 0-2 Calle 22, Paseo Colon del Restaurante La, Bastilla 50 metros Sur, Edificio 5.</name>
      <address>
        <city>San Jose</city>
        <country>Costa Rica</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Costa Rica</country>
  </location_countries>
  <results_reference>
    <citation>Arguedas A, Soley C, Abdelnour A, Sales V, Lindert K, Della Cioppa G, Clemens R; Costa Rican H1N1 Vaccine Study Group. Assessment of the safety, tolerability and kinetics of the immune response to A/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of age. Hum Vaccin. 2011 Jan 1;7(1):58-66. Epub 2011 Jan 1.</citation>
    <PMID>21285531</PMID>
  </results_reference>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 2, 2009</study_first_submitted>
  <study_first_submitted_qc>September 7, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2009</study_first_posted>
  <results_first_submitted>October 20, 2010</results_first_submitted>
  <results_first_submitted_qc>April 22, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 23, 2011</results_first_posted>
  <last_update_submitted>October 29, 2015</last_update_submitted>
  <last_update_submitted_qc>October 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Swine Flu</keyword>
  <keyword>Flu</keyword>
  <keyword>Vaccine</keyword>
  <keyword>Adjuvant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Influenza, Human</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
    <mesh_term>MF59 oil emulsion</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were enrolled at one center in Costa Rica.</recruitment_details>
      <pre_assignment_details>All enrolled subjects were included in the trial.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>2x7.5adj</title>
          <description>A/H1N1 7.5 mcg with MF59; two doses on day 1</description>
        </group>
        <group group_id="P2">
          <title>7.5adj_1_8</title>
          <description>A/H1N1 7.5 mcg with MF59; one dose on days 1 and 8</description>
        </group>
        <group group_id="P3">
          <title>7.5adj_1_22</title>
          <description>A/H1N1 7.5 mcg with MF59; one dose on days 1 and 22</description>
        </group>
        <group group_id="P4">
          <title>15_1_22</title>
          <description>A/H1N1 15 mcg no MF59; one dose on days 1 and 22</description>
        </group>
        <group group_id="P5">
          <title>2x15_1_22</title>
          <description>A/H1N1 15 mcg no MF59; two doses on days 1 and 22</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
                <participants group_id="P2" count="56"/>
                <participants group_id="P3" count="168"/>
                <participants group_id="P4" count="336"/>
                <participants group_id="P5" count="168"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
                <participants group_id="P2" count="54"/>
                <participants group_id="P3" count="158"/>
                <participants group_id="P4" count="318"/>
                <participants group_id="P5" count="158"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="10"/>
                <participants group_id="P4" count="18"/>
                <participants group_id="P5" count="10"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="8"/>
                <participants group_id="P5" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Inappropriate enrolment</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Unable to Classify</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>2x7.5adj</title>
          <description>A/H1N1 7.5 mcg with MF59; two doses on day 1</description>
        </group>
        <group group_id="B2">
          <title>7.5adj_1_8</title>
          <description>A/H1N1 7.5 mcg with MF59; one dose on days 1 and 8</description>
        </group>
        <group group_id="B3">
          <title>7.5adj_1_22</title>
          <description>A/H1N1 7.5 mcg with MF59; one dose on days 1 and 22</description>
        </group>
        <group group_id="B4">
          <title>15_1_22</title>
          <description>A/H1N1 15 mcg no MF59; one dose on days 1 and 22</description>
        </group>
        <group group_id="B5">
          <title>2x15_1_22</title>
          <description>A/H1N1 15 mcg no MF59; two doses on days 1 and 22</description>
        </group>
        <group group_id="B6">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="56"/>
            <count group_id="B2" value="56"/>
            <count group_id="B3" value="168"/>
            <count group_id="B4" value="336"/>
            <count group_id="B5" value="168"/>
            <count group_id="B6" value="784"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <description>The number of participants analyzed for each outcome measure below is not the same with the numbers provided in the participant flow module as this number is based on the age and/or the group analyses.</description>
          <units>subjects</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>3 to &lt; 9 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0" spread="0"/>
                    <measurement group_id="B2" value="0" spread="0"/>
                    <measurement group_id="B3" value="56" spread="1.7"/>
                    <measurement group_id="B4" value="84" spread="1.7"/>
                    <measurement group_id="B5" value="56" spread="1.9"/>
                    <measurement group_id="B6" value="196"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 to 17 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0" spread="0"/>
                    <measurement group_id="B2" value="0" spread="0"/>
                    <measurement group_id="B3" value="56" spread="2.5"/>
                    <measurement group_id="B4" value="84" spread="2.3"/>
                    <measurement group_id="B5" value="56" spread="2.5"/>
                    <measurement group_id="B6" value="196"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 to 64 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56" spread="10.8"/>
                    <measurement group_id="B2" value="56" spread="11.1"/>
                    <measurement group_id="B3" value="56" spread="11.2"/>
                    <measurement group_id="B4" value="168" spread="11.7"/>
                    <measurement group_id="B5" value="56" spread="11.0"/>
                    <measurement group_id="B6" value="392"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender, Customized</title>
          <units>Subjects</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female (3 to &lt;9 years)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="29"/>
                    <measurement group_id="B4" value="46"/>
                    <measurement group_id="B5" value="23"/>
                    <measurement group_id="B6" value="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male (3 to &lt; 9 years)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="27"/>
                    <measurement group_id="B4" value="38"/>
                    <measurement group_id="B5" value="33"/>
                    <measurement group_id="B6" value="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Female (9 to 17 years)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="40"/>
                    <measurement group_id="B4" value="40"/>
                    <measurement group_id="B5" value="30"/>
                    <measurement group_id="B6" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male (9 to 17 years)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="44"/>
                    <measurement group_id="B5" value="26"/>
                    <measurement group_id="B6" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Female (18 to 64 years)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="29"/>
                    <measurement group_id="B4" value="96"/>
                    <measurement group_id="B5" value="29"/>
                    <measurement group_id="B6" value="227"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male (18 to 64 years)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="27"/>
                    <measurement group_id="B4" value="72"/>
                    <measurement group_id="B5" value="27"/>
                    <measurement group_id="B6" value="165"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Subjects With Seroconversion and HI Titer ≥1:40 in Children 3 to 17 Years of Age</title>
        <description>Seroconversion: The percentage of subjects with either a pre-vaccination HI titer &lt; 1:10 and a post-vaccination HI titer &gt;1:40 or a prevaccination HI titer &gt;1:10 and a minimum four-fold rise in post-vaccination HI antibody titer.
The analyses were performed on the Per-Protocol Set (PPS).</description>
        <time_frame>Day 1 to day 387</time_frame>
        <population>The analysis was done on the per-protocol set.</population>
        <group_list>
          <group group_id="O1">
            <title>15_1_22</title>
            <description>A/H1N1 15 mcg no MF59; one dose on days 1 and 22</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects With Seroconversion and HI Titer ≥1:40 in Children 3 to 17 Years of Age</title>
          <description>Seroconversion: The percentage of subjects with either a pre-vaccination HI titer &lt; 1:10 and a post-vaccination HI titer &gt;1:40 or a prevaccination HI titer &gt;1:10 and a minimum four-fold rise in post-vaccination HI antibody titer.
The analyses were performed on the Per-Protocol Set (PPS).</description>
          <population>The analysis was done on the per-protocol set.</population>
          <units>Percentages of Subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="149"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>HI Titer ≥40 on day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26" lower_limit="19" upper_limit="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 22</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83" lower_limit="76" upper_limit="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 29</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95" lower_limit="91" upper_limit="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 43</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92" lower_limit="86" upper_limit="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 217 (N=129)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88" lower_limit="81" upper_limit="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 387 (N=136)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80" lower_limit="72" upper_limit="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 22</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79" lower_limit="71" upper_limit="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 29</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92" lower_limit="86" upper_limit="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 43</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87" lower_limit="81" upper_limit="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 217 (N=129)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71" lower_limit="62" upper_limit="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 387 (N=136)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63" lower_limit="54" upper_limit="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Subjects With Seroconversion and HI Titer ≥ 1:40 in Adults 18 to 64 Years of Age</title>
        <description>Seroconversion: The percentage of subjects with either a pre-vaccination HI titer &lt; 1:10 and a post-vaccination HI titer &gt;1:40 or a prevaccination HI titer &gt;1:10 and a minimum four-fold rise in post-vaccination HI antibody titer.
Analyses were performed on the Per-Protocol set (PPS).</description>
        <time_frame>Day 1 to day 387</time_frame>
        <population>The analysis was done on the per-protocol set.</population>
        <group_list>
          <group group_id="O1">
            <title>15_1_22</title>
            <description>A/H1N1 on study days 1 and 22</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects With Seroconversion and HI Titer ≥ 1:40 in Adults 18 to 64 Years of Age</title>
          <description>Seroconversion: The percentage of subjects with either a pre-vaccination HI titer &lt; 1:10 and a post-vaccination HI titer &gt;1:40 or a prevaccination HI titer &gt;1:10 and a minimum four-fold rise in post-vaccination HI antibody titer.
Analyses were performed on the Per-Protocol set (PPS).</description>
          <population>The analysis was done on the per-protocol set.</population>
          <units>Percentages of Subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="132"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>HI Titer ≥40 on day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18" lower_limit="12" upper_limit="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93" lower_limit="87" upper_limit="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99" lower_limit="96" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 22</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98" lower_limit="95" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 29</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99" lower_limit="96" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on Day 43</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="97" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on Day 217 (N=111)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91" lower_limit="84" upper_limit="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on Day 387 (N=120)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84" lower_limit="76" upper_limit="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86" lower_limit="78" upper_limit="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94" lower_limit="88" upper_limit="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 22</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94" lower_limit="88" upper_limit="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 29</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95" lower_limit="90" upper_limit="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 43</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95" lower_limit="90" upper_limit="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 217 (N=111)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81" lower_limit="73" upper_limit="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 387 (N=120)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75" lower_limit="66" upper_limit="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Age Distribution at Baseline</title>
        <time_frame>Baseline</time_frame>
        <population>The overall number of baseline participants.</population>
        <group_list>
          <group group_id="O1">
            <title>2x7.5adj</title>
            <description>A/H1N1 7.5 mcg with MF59; two doses on day 1</description>
          </group>
          <group group_id="O2">
            <title>7.5adj_1_8</title>
            <description>A/H1N1 7.5 mcg with MF59; two doses on day 1</description>
          </group>
          <group group_id="O3">
            <title>7.5adj_1_22</title>
            <description>A/H1N1 7.5 mcg with MF59; two doses on day 1</description>
          </group>
          <group group_id="O4">
            <title>15_1_22</title>
            <description>A/H1N1 7.5 mcg with MF59; two doses on day 1</description>
          </group>
          <group group_id="O5">
            <title>2x15_1_22</title>
            <description>A/H1N1 7.5 mcg with MF59; two doses on day 1</description>
          </group>
        </group_list>
        <measure>
          <title>Age Distribution at Baseline</title>
          <population>The overall number of baseline participants.</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="56"/>
                <count group_id="O3" value="168"/>
                <count group_id="O4" value="336"/>
                <count group_id="O5" value="168"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>3 to &lt;9 years (N=0, 0, 56, 84, 56)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">Not Applicable (NA) as 0 subjects were in this category.</measurement>
                    <measurement group_id="O2" value="NA">Not Applicable (NA) as 0 subjects were in this category.</measurement>
                    <measurement group_id="O3" value="5.5" spread="1.7"/>
                    <measurement group_id="O4" value="5.7" spread="1.7"/>
                    <measurement group_id="O5" value="5.4" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9 to 17 years (N=0, 0, 56, 84, 56)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">Not Applicable (NA) as 0 subjects were in this category.</measurement>
                    <measurement group_id="O2" value="NA">Not Applicable (NA) as 0 subjects were in this category.</measurement>
                    <measurement group_id="O3" value="13.1" spread="2.5"/>
                    <measurement group_id="O4" value="12.8" spread="2.3"/>
                    <measurement group_id="O5" value="13.1" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 to 64 years (N= 56, 56, 56, 168, 56)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.1" spread="10.8"/>
                    <measurement group_id="O2" value="38.6" spread="11.1"/>
                    <measurement group_id="O3" value="37.3" spread="11.2"/>
                    <measurement group_id="O4" value="37.0" spread="11.7"/>
                    <measurement group_id="O5" value="37.4" spread="11.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Subjects With Seroconversion and HI Titer ≥1:40, in 3 to &lt;9 Years and 9 to 17 Years</title>
        <description>Seroconversion: The percentage of subjects with either a pre-vaccination HI titer &lt; 1:10 and a post-vaccination HI titer &gt;1:40 or a prevaccination HI titer &gt;1:10 and a minimum four-fold rise in post-vaccination HI antibody titer.
The analyses were performed on the Per-Protocol Set (PPS).</description>
        <time_frame>Day 1 to day 387</time_frame>
        <population>The analysis is done on the per-protocol set.</population>
        <group_list>
          <group group_id="O1">
            <title>7.5adj_1_22</title>
            <description>A/H1N1 7.5 mcg with MF59; one dose on days 1 and 22</description>
          </group>
          <group group_id="O2">
            <title>15_1_22</title>
            <description>A/H1N1 15 mcg no MF59; one dose on days 1 and 22</description>
          </group>
          <group group_id="O3">
            <title>2x15_1_22</title>
            <description>A/H1N1 15 mcg no MF59; two doses on days 1 and 22</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects With Seroconversion and HI Titer ≥1:40, in 3 to &lt;9 Years and 9 to 17 Years</title>
          <description>Seroconversion: The percentage of subjects with either a pre-vaccination HI titer &lt; 1:10 and a post-vaccination HI titer &gt;1:40 or a prevaccination HI titer &gt;1:10 and a minimum four-fold rise in post-vaccination HI antibody titer.
The analyses were performed on the Per-Protocol Set (PPS).</description>
          <population>The analysis is done on the per-protocol set.</population>
          <units>Percentages of Subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="91"/>
                <count group_id="O2" value="149"/>
                <count group_id="O3" value="99"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>HI Titer ≥40 on day 1 (3 to &lt;9 yrs; N=46,75,47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24" lower_limit="13" upper_limit="39"/>
                    <measurement group_id="O2" value="23" lower_limit="14" upper_limit="34"/>
                    <measurement group_id="O3" value="23" lower_limit="12" upper_limit="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 22 (3 to &lt;9 yrs; N=46,75,47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93" lower_limit="82" upper_limit="99"/>
                    <measurement group_id="O2" value="71" lower_limit="59" upper_limit="81"/>
                    <measurement group_id="O3" value="79" lower_limit="64" upper_limit="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 29 (3 to &lt; 9 yrs; N=46,75,47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="92" upper_limit="100"/>
                    <measurement group_id="O2" value="92" lower_limit="83" upper_limit="97"/>
                    <measurement group_id="O3" value="96" lower_limit="85" upper_limit="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 43 (3 to &lt; 9 yrs; N=46,75,47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="92" upper_limit="100"/>
                    <measurement group_id="O2" value="85" lower_limit="75" upper_limit="92"/>
                    <measurement group_id="O3" value="96" lower_limit="85" upper_limit="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 217 (3 to &lt; 9 yrs; N=41,66,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="91" upper_limit="100"/>
                    <measurement group_id="O2" value="80" lower_limit="69" upper_limit="89"/>
                    <measurement group_id="O3" value="78" lower_limit="62" upper_limit="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 387 (3 to &lt; 9 yrs; N=43,70,42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93" lower_limit="81" upper_limit="99"/>
                    <measurement group_id="O2" value="73" lower_limit="61" upper_limit="83"/>
                    <measurement group_id="O3" value="62" lower_limit="46" upper_limit="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 22 (3 to &lt;9 yrs; N=46,75,47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91" lower_limit="79" upper_limit="98"/>
                    <measurement group_id="O2" value="69" lower_limit="58" upper_limit="79"/>
                    <measurement group_id="O3" value="79" lower_limit="64" upper_limit="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 29 (3 to &lt;9 yrs; N=46,75,47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98" lower_limit="88" upper_limit="100"/>
                    <measurement group_id="O2" value="92" lower_limit="83" upper_limit="97"/>
                    <measurement group_id="O3" value="96" lower_limit="85" upper_limit="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 43 (3 to &lt;9 yrs; N=46,75,47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96" lower_limit="85" upper_limit="99"/>
                    <measurement group_id="O2" value="84" lower_limit="74" upper_limit="91"/>
                    <measurement group_id="O3" value="94" lower_limit="82" upper_limit="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 217 (3 to &lt;9 yrs;N=41,66,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88" lower_limit="74" upper_limit="96"/>
                    <measurement group_id="O2" value="65" lower_limit="52" upper_limit="76"/>
                    <measurement group_id="O3" value="65" lower_limit="48" upper_limit="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 387 (3 to &lt;9 yrs;N=43,70,42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77" lower_limit="61" upper_limit="88"/>
                    <measurement group_id="O2" value="56" lower_limit="43" upper_limit="68"/>
                    <measurement group_id="O3" value="50" lower_limit="34" upper_limit="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 1 (9 to 17 yrs;N=45,74,52)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42" lower_limit="28" upper_limit="58"/>
                    <measurement group_id="O2" value="28" lower_limit="19" upper_limit="40"/>
                    <measurement group_id="O3" value="33" lower_limit="20" upper_limit="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 22 (9 to 17 yrs; N=45,74,52)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98" lower_limit="88" upper_limit="100"/>
                    <measurement group_id="O2" value="96" lower_limit="89" upper_limit="99"/>
                    <measurement group_id="O3" value="100" lower_limit="93" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 29 (9 to 17 yrs; N=45,74,52)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="92" upper_limit="100"/>
                    <measurement group_id="O2" value="99" lower_limit="93" upper_limit="100"/>
                    <measurement group_id="O3" value="100" lower_limit="93" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 43 (9 to 17 yrs; N=45,74,52)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="92" upper_limit="100"/>
                    <measurement group_id="O2" value="99" lower_limit="93" upper_limit="100"/>
                    <measurement group_id="O3" value="100" lower_limit="93" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 217 (9 to 17 yrs; N=37,63,45)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="91" upper_limit="100"/>
                    <measurement group_id="O2" value="95" lower_limit="87" upper_limit="99"/>
                    <measurement group_id="O3" value="98" lower_limit="88" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 387 (9 to 17 yrs; N=37,66,47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89" lower_limit="75" upper_limit="97"/>
                    <measurement group_id="O2" value="88" lower_limit="78" upper_limit="95"/>
                    <measurement group_id="O3" value="89" lower_limit="77" upper_limit="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 22 (9 to 17 yrs; N=45,74,52)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87" lower_limit="73" upper_limit="95"/>
                    <measurement group_id="O2" value="88" lower_limit="78" upper_limit="94"/>
                    <measurement group_id="O3" value="94" lower_limit="84" upper_limit="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 29 (9 to 17 yrs; N=45,74,52)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89" lower_limit="76" upper_limit="96"/>
                    <measurement group_id="O2" value="92" lower_limit="83" upper_limit="97"/>
                    <measurement group_id="O3" value="94" lower_limit="84" upper_limit="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 43 (9 to 17 yrs; N=45,74,52)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84" lower_limit="71" upper_limit="94"/>
                    <measurement group_id="O2" value="91" lower_limit="81" upper_limit="96"/>
                    <measurement group_id="O3" value="92" lower_limit="81" upper_limit="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 217 (9 to 17 yrs;N=37,63,45)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68" lower_limit="50" upper_limit="82"/>
                    <measurement group_id="O2" value="76" lower_limit="64" upper_limit="86"/>
                    <measurement group_id="O3" value="76" lower_limit="60" upper_limit="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 387 (9 to 17 yrs;N=37,66,47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59" lower_limit="42" upper_limit="75"/>
                    <measurement group_id="O2" value="70" lower_limit="57" upper_limit="80"/>
                    <measurement group_id="O3" value="70" lower_limit="55" upper_limit="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>HI GMRs, in 3 to &lt;9 Years and 9 to 17 Years</title>
        <description>Geometric Mean Ratios (GMRs) of hemagglutination inhibition (HI) antibody assay (ratio of post-vaccination versus pre-vaccination HI titers).
The analyses were performed on the the per-protocol set (PPS).</description>
        <time_frame>Day 1 to day 387</time_frame>
        <population>The analysis is done on the per-protocol set.</population>
        <group_list>
          <group group_id="O1">
            <title>7.5adj_1_22</title>
            <description>A/H1N1 7.5 mcg with MF59; one dose on days 1 and 22</description>
          </group>
          <group group_id="O2">
            <title>15_1_22</title>
            <description>A/H1N1 15 mcg no MF59; one dose on days 1 and 22</description>
          </group>
          <group group_id="O3">
            <title>2x15_1_22</title>
            <description>A/H1N1 15 mcg no MF59; two doses on days 1 and 22</description>
          </group>
        </group_list>
        <measure>
          <title>HI GMRs, in 3 to &lt;9 Years and 9 to 17 Years</title>
          <description>Geometric Mean Ratios (GMRs) of hemagglutination inhibition (HI) antibody assay (ratio of post-vaccination versus pre-vaccination HI titers).
The analyses were performed on the the per-protocol set (PPS).</description>
          <population>The analysis is done on the per-protocol set.</population>
          <units>Ratio</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="91"/>
                <count group_id="O2" value="149"/>
                <count group_id="O3" value="99"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>GMR on day 22 (3 to &lt; 9 yrs; N=46,75,47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31" lower_limit="19" upper_limit="50"/>
                    <measurement group_id="O2" value="12" lower_limit="8.51" upper_limit="18"/>
                    <measurement group_id="O3" value="16" lower_limit="10" upper_limit="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMR on day 29 (3 to &lt; 9 yrs; N=46,75,47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="169" lower_limit="110" upper_limit="260"/>
                    <measurement group_id="O2" value="35" lower_limit="24" upper_limit="49"/>
                    <measurement group_id="O3" value="53" lower_limit="35" upper_limit="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMR on day 43 (3 to &lt; 9 yrs; N=46,75,47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120" lower_limit="75" upper_limit="192"/>
                    <measurement group_id="O2" value="22" lower_limit="15" upper_limit="32"/>
                    <measurement group_id="O3" value="44" lower_limit="27" upper_limit="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMR on day 217 (3 to &lt;9 yrs; N=41,66,40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19" lower_limit="12" upper_limit="30"/>
                    <measurement group_id="O2" value="7.79" lower_limit="5.46" upper_limit="11"/>
                    <measurement group_id="O3" value="8.07" lower_limit="5.11" upper_limit="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMR on day 387 (3 to &lt;9 yrs; N=43,70,42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14" lower_limit="8.27" upper_limit="24"/>
                    <measurement group_id="O2" value="6.9" lower_limit="4.58" upper_limit="10"/>
                    <measurement group_id="O3" value="5.94" lower_limit="3.5" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMR on day 22 (9 to 17 yrs; N=45,74,52)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42" lower_limit="24" upper_limit="74"/>
                    <measurement group_id="O2" value="52" lower_limit="34" upper_limit="81"/>
                    <measurement group_id="O3" value="66" lower_limit="39" upper_limit="111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMR on day 29 (9 to 17 yrs; N=45,74,52)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63" lower_limit="36" upper_limit="109"/>
                    <measurement group_id="O2" value="70" lower_limit="45" upper_limit="108"/>
                    <measurement group_id="O3" value="79" lower_limit="47" upper_limit="132"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMR on day 43 (9 to 17 yrs; N=45,74,52)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44" lower_limit="25" upper_limit="77"/>
                    <measurement group_id="O2" value="48" lower_limit="31" upper_limit="75"/>
                    <measurement group_id="O3" value="59" lower_limit="35" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMR on day 217 (9 to 17 yrs; N=37,63,45)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" lower_limit="5.66" upper_limit="18"/>
                    <measurement group_id="O2" value="17" lower_limit="11" upper_limit="26"/>
                    <measurement group_id="O3" value="13" lower_limit="7.92" upper_limit="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMR on day 387 (9 to 17 yrs; N=37,66,47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.22" lower_limit="3.77" upper_limit="14"/>
                    <measurement group_id="O2" value="16" lower_limit="9.53" upper_limit="25"/>
                    <measurement group_id="O3" value="13" lower_limit="7.53" upper_limit="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>HI GMR, in Adults 18 to 64 Years</title>
        <description>Geometric Mean Ratios (GMRs) of hemagglutination inhibition (HI) antibody assay (ratio of post-vaccination versus pre-vaccination HI titers).
The analyses were performed on the Per-Protocol Set (PPS).</description>
        <time_frame>Day 1 to day 387</time_frame>
        <population>The analysis is done on the per-protocol set.</population>
        <group_list>
          <group group_id="O1">
            <title>2x7.5adj</title>
            <description>A/H1N1 7.5 mcg with MF59; two doses on day 1</description>
          </group>
          <group group_id="O2">
            <title>7.5adj_1_8</title>
            <description>A/H1N1 7.5 mcg with MF59; one dose on days 1 and 8</description>
          </group>
          <group group_id="O3">
            <title>7.5adj_1_22</title>
            <description>A/H1N1 7.5 mcg with MF59; one dose on days 1 and 22</description>
          </group>
          <group group_id="O4">
            <title>15_1_22</title>
            <description>A/H1N1 15 mcg no MF59; one dose on days 1 and 22</description>
          </group>
          <group group_id="O5">
            <title>2x15_1_22</title>
            <description>A/H1N1 15 mcg no MF59; two doses on days 1 and 22</description>
          </group>
        </group_list>
        <measure>
          <title>HI GMR, in Adults 18 to 64 Years</title>
          <description>Geometric Mean Ratios (GMRs) of hemagglutination inhibition (HI) antibody assay (ratio of post-vaccination versus pre-vaccination HI titers).
The analyses were performed on the Per-Protocol Set (PPS).</description>
          <population>The analysis is done on the per-protocol set.</population>
          <units>Ratio</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="132"/>
                <count group_id="O5" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>GMR on day 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48" lower_limit="28" upper_limit="85"/>
                    <measurement group_id="O2" value="35" lower_limit="21" upper_limit="60"/>
                    <measurement group_id="O3" value="57" lower_limit="33" upper_limit="97"/>
                    <measurement group_id="O4" value="43" lower_limit="32" upper_limit="59"/>
                    <measurement group_id="O5" value="63" lower_limit="37" upper_limit="106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMR on day 15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="115" lower_limit="70" upper_limit="189"/>
                    <measurement group_id="O2" value="181" lower_limit="113" upper_limit="292"/>
                    <measurement group_id="O3" value="200" lower_limit="124" upper_limit="322"/>
                    <measurement group_id="O4" value="138" lower_limit="104" upper_limit="182"/>
                    <measurement group_id="O5" value="123" lower_limit="77" upper_limit="197"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMR on day 22</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79" lower_limit="48" upper_limit="130"/>
                    <measurement group_id="O2" value="100" lower_limit="63" upper_limit="160"/>
                    <measurement group_id="O3" value="123" lower_limit="77" upper_limit="197"/>
                    <measurement group_id="O4" value="85" lower_limit="64" upper_limit="111"/>
                    <measurement group_id="O5" value="72" lower_limit="45" upper_limit="113"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMR on day 29</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56" lower_limit="35" upper_limit="89"/>
                    <measurement group_id="O2" value="76" lower_limit="49" upper_limit="118"/>
                    <measurement group_id="O3" value="160" lower_limit="103" upper_limit="248"/>
                    <measurement group_id="O4" value="83" lower_limit="64" upper_limit="107"/>
                    <measurement group_id="O5" value="66" lower_limit="43" upper_limit="101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMR on day 43</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44" lower_limit="27" upper_limit="71"/>
                    <measurement group_id="O2" value="64" lower_limit="40" upper_limit="101"/>
                    <measurement group_id="O3" value="101" lower_limit="63" upper_limit="161"/>
                    <measurement group_id="O4" value="76" lower_limit="58" upper_limit="100"/>
                    <measurement group_id="O5" value="65" lower_limit="41" upper_limit="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMR on day (N=0,0,35,111,34)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">Zero subjects were enrolled in this group.</measurement>
                    <measurement group_id="O2" value="NA">Zero subjects were enrolled in this group.</measurement>
                    <measurement group_id="O3" value="30" lower_limit="18" upper_limit="48"/>
                    <measurement group_id="O4" value="16" lower_limit="12" upper_limit="20"/>
                    <measurement group_id="O5" value="16" lower_limit="10" upper_limit="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GMR on day 387 (N=38,40,38,120,42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.61" lower_limit="3.92" upper_limit="11"/>
                    <measurement group_id="O2" value="11" lower_limit="6.81" upper_limit="19"/>
                    <measurement group_id="O3" value="21" lower_limit="12" upper_limit="36"/>
                    <measurement group_id="O4" value="12" lower_limit="8.99" upper_limit="16"/>
                    <measurement group_id="O5" value="9.21" lower_limit="5.61" upper_limit="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Subjects With Seroconversion and HI Titer ≥1:40, in Adults 18 to 64 Years</title>
        <description>Seroconversion: The percentage of subjects with either a pre-vaccination HI titer &lt; 1:10 and a post-vaccination HI titer &gt;1:40 or a prevaccination HI titer &gt;1:10 and a minimum four-fold rise in post-vaccination HI antibody titer.
The analyses were performed on the per-protocol set (PPS).</description>
        <time_frame>7 days and 21 days after each vaccination</time_frame>
        <population>The analysis is done on the per-protocol set.</population>
        <group_list>
          <group group_id="O1">
            <title>2x7.5adj</title>
            <description>A/H1N1 7.5 mcg with MF59; two doses on day 1</description>
          </group>
          <group group_id="O2">
            <title>7.5adj_1_8</title>
            <description>A/H1N1 7.5 mcg with MF59; one dose on days 1 and 8</description>
          </group>
          <group group_id="O3">
            <title>7.5adj_1_22</title>
            <description>A/H1N1 7.5 mcg with MF59; one dose on days 1 and 22</description>
          </group>
          <group group_id="O4">
            <title>15_1_22</title>
            <description>A/H1N1 15 mcg no MF59; one dose on days 1 and 22</description>
          </group>
          <group group_id="O5">
            <title>2x15_1_22</title>
            <description>A/H1N1 15 mcg no MF59; two doses on days 1 and 22</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects With Seroconversion and HI Titer ≥1:40, in Adults 18 to 64 Years</title>
          <description>Seroconversion: The percentage of subjects with either a pre-vaccination HI titer &lt; 1:10 and a post-vaccination HI titer &gt;1:40 or a prevaccination HI titer &gt;1:10 and a minimum four-fold rise in post-vaccination HI antibody titer.
The analyses were performed on the per-protocol set (PPS).</description>
          <population>The analysis is done on the per-protocol set.</population>
          <units>Percentages of Subjects</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="132"/>
                <count group_id="O5" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>HI Titer ≥40 on day 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="91" upper_limit="100"/>
                    <measurement group_id="O2" value="91" lower_limit="79" upper_limit="98"/>
                    <measurement group_id="O3" value="96" lower_limit="85" upper_limit="99"/>
                    <measurement group_id="O4" value="93" lower_limit="87" upper_limit="97"/>
                    <measurement group_id="O5" value="96" lower_limit="85" upper_limit="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="91" upper_limit="100"/>
                    <measurement group_id="O2" value="100" lower_limit="92" upper_limit="100"/>
                    <measurement group_id="O3" value="98" lower_limit="88" upper_limit="100"/>
                    <measurement group_id="O4" value="99" lower_limit="96" upper_limit="100"/>
                    <measurement group_id="O5" value="100" lower_limit="92" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 22</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="91" upper_limit="100"/>
                    <measurement group_id="O2" value="98" lower_limit="88" upper_limit="100"/>
                    <measurement group_id="O3" value="98" lower_limit="88" upper_limit="100"/>
                    <measurement group_id="O4" value="98" lower_limit="95" upper_limit="100"/>
                    <measurement group_id="O5" value="98" lower_limit="89" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 29</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="91" upper_limit="100"/>
                    <measurement group_id="O2" value="98" lower_limit="88" upper_limit="100"/>
                    <measurement group_id="O3" value="100" lower_limit="92" upper_limit="100"/>
                    <measurement group_id="O4" value="99" lower_limit="96" upper_limit="100"/>
                    <measurement group_id="O5" value="100" lower_limit="92" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 43</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98" lower_limit="87" upper_limit="100"/>
                    <measurement group_id="O2" value="100" lower_limit="92" upper_limit="100"/>
                    <measurement group_id="O3" value="98" lower_limit="88" upper_limit="100"/>
                    <measurement group_id="O4" value="100" lower_limit="97" upper_limit="100"/>
                    <measurement group_id="O5" value="100" lower_limit="92" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 217 (N=0,0,35,111,34)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">No subjects were analyzed for this group.</measurement>
                    <measurement group_id="O2" value="NA">No subjects were analyzed for this group.</measurement>
                    <measurement group_id="O3" value="97" lower_limit="85" upper_limit="100"/>
                    <measurement group_id="O4" value="91" lower_limit="84" upper_limit="96"/>
                    <measurement group_id="O5" value="97" lower_limit="85" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 387 (N=38,40,38,120,42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76" lower_limit="60" upper_limit="89"/>
                    <measurement group_id="O2" value="90" lower_limit="76" upper_limit="97"/>
                    <measurement group_id="O3" value="92" lower_limit="79" upper_limit="98"/>
                    <measurement group_id="O4" value="84" lower_limit="76" upper_limit="90"/>
                    <measurement group_id="O5" value="83" lower_limit="69" upper_limit="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95" lower_limit="83" upper_limit="99"/>
                    <measurement group_id="O2" value="80" lower_limit="65" upper_limit="90"/>
                    <measurement group_id="O3" value="93" lower_limit="82" upper_limit="99"/>
                    <measurement group_id="O4" value="86" lower_limit="78" upper_limit="91"/>
                    <measurement group_id="O5" value="94" lower_limit="82" upper_limit="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98" lower_limit="87" upper_limit="100"/>
                    <measurement group_id="O2" value="100" lower_limit="92" upper_limit="100"/>
                    <measurement group_id="O3" value="98" lower_limit="88" upper_limit="100"/>
                    <measurement group_id="O4" value="94" lower_limit="88" upper_limit="97"/>
                    <measurement group_id="O5" value="98" lower_limit="89" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 22</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95" lower_limit="83" upper_limit="99"/>
                    <measurement group_id="O2" value="91" lower_limit="79" upper_limit="98"/>
                    <measurement group_id="O3" value="96" lower_limit="85" upper_limit="99"/>
                    <measurement group_id="O4" value="94" lower_limit="88" upper_limit="97"/>
                    <measurement group_id="O5" value="96" lower_limit="85" upper_limit="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 29</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95" lower_limit="83" upper_limit="99"/>
                    <measurement group_id="O2" value="93" lower_limit="82" upper_limit="99"/>
                    <measurement group_id="O3" value="98" lower_limit="88" upper_limit="100"/>
                    <measurement group_id="O4" value="95" lower_limit="90" upper_limit="98"/>
                    <measurement group_id="O5" value="98" lower_limit="89" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 43</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85" lower_limit="71" upper_limit="94"/>
                    <measurement group_id="O2" value="93" lower_limit="82" upper_limit="99"/>
                    <measurement group_id="O3" value="96" lower_limit="85" upper_limit="99"/>
                    <measurement group_id="O4" value="95" lower_limit="90" upper_limit="98"/>
                    <measurement group_id="O5" value="98" lower_limit="89" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 217 (N=0,0,35,111,34)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">No subjects were analyzed for this group.</measurement>
                    <measurement group_id="O2" value="NA">No subjects were analyzed for this group.</measurement>
                    <measurement group_id="O3" value="94" lower_limit="81" upper_limit="99"/>
                    <measurement group_id="O4" value="81" lower_limit="73" upper_limit="88"/>
                    <measurement group_id="O5" value="88" lower_limit="73" upper_limit="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroconversion on day 387 (N=38,40,38,120,42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66" lower_limit="49" upper_limit="80"/>
                    <measurement group_id="O2" value="80" lower_limit="64" upper_limit="91"/>
                    <measurement group_id="O3" value="87" lower_limit="72" upper_limit="96"/>
                    <measurement group_id="O4" value="75" lower_limit="66" upper_limit="82"/>
                    <measurement group_id="O5" value="69" lower_limit="53" upper_limit="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HI Titer ≥40 on day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" lower_limit="9" upper_limit="35"/>
                    <measurement group_id="O2" value="22" lower_limit="11" upper_limit="37"/>
                    <measurement group_id="O3" value="13" lower_limit="5" upper_limit="27"/>
                    <measurement group_id="O4" value="18" lower_limit="12" upper_limit="26"/>
                    <measurement group_id="O5" value="21" lower_limit="11" upper_limit="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects With at Least One Reactogenicity Sign, in 3 to &lt;9 Years of Age</title>
        <description>Number of subjects with specified solicited local and systemic reactions in adult subjects (3 to &lt;9 years of age).
Postvac: postvaccination; Analges: analgesics; Antipyr: antipyretics. The analyses were performed on the safety set. Note: 1) postvac 1 = after the first vaccination and 2) postvac 2 = after the second vaccination</description>
        <time_frame>7 days after each vaccination</time_frame>
        <population>The analysis is done on the safety set.</population>
        <group_list>
          <group group_id="O1">
            <title>7.5adj_1_22</title>
            <description>A/H1N1 7.5 mcg with MF59; one dose on days 1 and 22</description>
          </group>
          <group group_id="O2">
            <title>15_1_22</title>
            <description>A/H1N1 15 mcg no MF59; one dose on days 1 and 22</description>
          </group>
          <group group_id="O3">
            <title>2x15_1_22</title>
            <description>A/H1N1 15 mcg no MF59; two doses on days 1 and 22</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With at Least One Reactogenicity Sign, in 3 to &lt;9 Years of Age</title>
          <description>Number of subjects with specified solicited local and systemic reactions in adult subjects (3 to &lt;9 years of age).
Postvac: postvaccination; Analges: analgesics; Antipyr: antipyretics. The analyses were performed on the safety set. Note: 1) postvac 1 = after the first vaccination and 2) postvac 2 = after the second vaccination</description>
          <population>The analysis is done on the safety set.</population>
          <units>Number of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="55"/>
                <count group_id="O2" value="84"/>
                <count group_id="O3" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Local Reactions postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="31"/>
                    <measurement group_id="O3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Induration postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tenderness postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="25"/>
                    <measurement group_id="O3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systemic Reaction postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="28"/>
                    <measurement group_id="O3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myalgia postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arthralgia postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chills postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other Reactions postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Analges/Antipyr Used postvac. 1 (N=55, 83, 54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stayed Home postvac.1(N=55,83,54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Body Temp &gt; 40 C postvac.1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Local Reactions postvac. 2 (N=55, 83, 54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="29"/>
                    <measurement group_id="O3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema postvac. 2 (N=55, 83, 54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Induration postvac. 2 (N=55, 83, 54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling postvac. 2 (N=55, 83, 54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tenderness postvac. 2 (N=55, 83, 54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="27"/>
                    <measurement group_id="O3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain postvac. 2 (N=55, 83, 54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systemic Reaction postvac. 2 (N=55, 83, 54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache postvac. 2 (N=55, 83, 54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue postvac. 2 (N=55, 83, 54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myalgia postvac. 2 (N=55, 83, 54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arthralgia postvac. 2 (N=55, 83, 54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chills postvac. 2 (N=55, 83, 54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea postvac. 2 (N=55, 83, 54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting postvac. 2 (N=55, 83, 54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea postvac. 2 (N=55, 83, 54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other Reactions postvac. 2 (N=55, 82, 54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Analges/Antipyr Used postvac. 2 (N=55, 83, 54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stayed Home postvac. 2 (N=55, 82, 54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Body Temp &gt; 40 C postvac. 2 (N=55, 83, 54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects With at Least One Reactogenicity Sign, in 9 to 17 Years of Age</title>
        <description>Number of subjects with specified solicited local and systemic reactions in adult subjects (9 to 17 years of age).
Postvac: postvaccination Analges: analgesics Antipyr: antipyretics The analyses were performed on the safety set.
Note: 1) postvac 1 = after the first vaccination and 2) postvac 2 = after the second vaccination.</description>
        <time_frame>7 days after each vaccination</time_frame>
        <population>The analysis is done on the safety set.</population>
        <group_list>
          <group group_id="O1">
            <title>7.5adj_1_22</title>
            <description>A/H1N1 7.5 mcg with MF59; one dose on days 1 and 22</description>
          </group>
          <group group_id="O2">
            <title>15_1_22</title>
            <description>A/H1N1 15 mcg no MF59; one dose on days 1 and 22</description>
          </group>
          <group group_id="O3">
            <title>2x15_1_22</title>
            <description>A/H1N1 15 mcg no MF59; two doses on days 1 and 22</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With at Least One Reactogenicity Sign, in 9 to 17 Years of Age</title>
          <description>Number of subjects with specified solicited local and systemic reactions in adult subjects (9 to 17 years of age).
Postvac: postvaccination Analges: analgesics Antipyr: antipyretics The analyses were performed on the safety set.
Note: 1) postvac 1 = after the first vaccination and 2) postvac 2 = after the second vaccination.</description>
          <population>The analysis is done on the safety set.</population>
          <units>Number of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="84"/>
                <count group_id="O3" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Local Reactions postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="36"/>
                    <measurement group_id="O3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Induration postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tenderness postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="30"/>
                    <measurement group_id="O3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systemic Reaction postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="36"/>
                    <measurement group_id="O3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="20"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myalgia postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arthralgia postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chills postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other Reactions postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Analgesic/Antipyretic Used postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stayed Home postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Body Temp &gt; 40 C postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Local Reactions postvac. 2 (N=52, 84, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="36"/>
                    <measurement group_id="O3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema postvac. 2 (N=52, 84, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Induration postvac. 2 (N=52, 84, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling postvac. 2 (N=52, 84, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tenderness postvac. 2 (N=52, 84, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="25"/>
                    <measurement group_id="O3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain postvac. 2 (N=52, 84, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                    <measurement group_id="O2" value="30"/>
                    <measurement group_id="O3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systemic Reaction postvac. 2 (N=52, 84, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="29"/>
                    <measurement group_id="O3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache postvac. 2 (N=52, 84, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue postvac. 2 (N=52, 84, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myalgia postvac. 2 (N=52, 84, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arthralgia postvac. 2 (N=52, 84, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chills postvac. 2 (N=52, 84, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea postvac. 2 (N=52, 84, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting postvac. 2 (N=52, 84, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea postvac. 2 (N=52, 84, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other Reactions postvac. 2 (N=52, 84, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Analges/Antipyr Used postvac. 2 (N=52, 84, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stayed Home postvac. 2 (N=52, 84, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Body Temp &gt; 40 C postvac. 2 (N=52, 84, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects With at Least One Reactogenicity Sign, in 18 to 64 Years of Age</title>
        <description>Number of subjects with specified solicited local and systemic reactions in adult subjects (18 to 64 years of age).
Note: 1) postvac. 1 = after the first vaccination and 2) postvac. 2 = after the second vaccination.
The analyses were performed on the safety set.</description>
        <time_frame>7 days after each vaccination</time_frame>
        <population>The analysis is done on the safety set.</population>
        <group_list>
          <group group_id="O1">
            <title>2x7.5adj</title>
            <description>A/H1N1 7.5 mcg with MF59; two doses on day 1</description>
          </group>
          <group group_id="O2">
            <title>7.5adj_1_8</title>
            <description>A/H1N1 7.5 mcg with MF59; one dose on days 1 and 8</description>
          </group>
          <group group_id="O3">
            <title>7.5adj_1_22</title>
            <description>A/H1N1 7.5 mcg with MF59; one dose on days 1 and 22</description>
          </group>
          <group group_id="O4">
            <title>15_1_22</title>
            <description>A/H1N1 15 mcg no MF59; one dose on days 1 and 22</description>
          </group>
          <group group_id="O5">
            <title>2x15_1_22</title>
            <description>A/H1N1 15 mcg no MF59; two doses on days 1 and 22</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With at Least One Reactogenicity Sign, in 18 to 64 Years of Age</title>
          <description>Number of subjects with specified solicited local and systemic reactions in adult subjects (18 to 64 years of age).
Note: 1) postvac. 1 = after the first vaccination and 2) postvac. 2 = after the second vaccination.
The analyses were performed on the safety set.</description>
          <population>The analysis is done on the safety set.</population>
          <units>Number of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="56"/>
                <count group_id="O3" value="56"/>
                <count group_id="O4" value="159"/>
                <count group_id="O5" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Local Reactions postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="38"/>
                    <measurement group_id="O4" value="56"/>
                    <measurement group_id="O5" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Induration postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tenderness postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="26"/>
                    <measurement group_id="O4" value="35"/>
                    <measurement group_id="O5" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O3" value="32"/>
                    <measurement group_id="O4" value="41"/>
                    <measurement group_id="O5" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systemic Reaction postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="31"/>
                    <measurement group_id="O3" value="31"/>
                    <measurement group_id="O4" value="71"/>
                    <measurement group_id="O5" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="22"/>
                    <measurement group_id="O4" value="42"/>
                    <measurement group_id="O5" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="16"/>
                    <measurement group_id="O4" value="32"/>
                    <measurement group_id="O5" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myalgia postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="16"/>
                    <measurement group_id="O4" value="28"/>
                    <measurement group_id="O5" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arthralgia postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chills postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="16"/>
                    <measurement group_id="O5" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other Reactions postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Analgesic/Antipyretic Used postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stayed Home postvac. 1 (N=53,55,56,157,54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Body Temp &gt; 40 C postvac. 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Local Reactions postvac. 2 (N=0,55,56,158,53)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="28"/>
                    <measurement group_id="O4" value="56"/>
                    <measurement group_id="O5" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Erythema postvac. 2 (N=0,55,56,158,53)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Induration postvac. 2 (N=0,55,56,158,53)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling postvac. 2 (N=0,55,56,158,53)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tenderness postvac. 2 (N=0,55,56,157853)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="24"/>
                    <measurement group_id="O4" value="48"/>
                    <measurement group_id="O5" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain postvac. 2 (N=0,55,56,158,53)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="19"/>
                    <measurement group_id="O3" value="24"/>
                    <measurement group_id="O4" value="45"/>
                    <measurement group_id="O5" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systemic Reaction postvac. 2 (N=0,55,56,158,53)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="28"/>
                    <measurement group_id="O4" value="53"/>
                    <measurement group_id="O5" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache postvac. 2 (N=0,55,56,158, 53)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="25"/>
                    <measurement group_id="O5" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue postvac. 2 (N=0,55,56,158, 53)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="24"/>
                    <measurement group_id="O5" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myalgia postvac. 2 (N=0,55,56,158, 53)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="26"/>
                    <measurement group_id="O5" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arthralgia postvac. 2 (N=0,55,56,158, 53)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="16"/>
                    <measurement group_id="O5" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chills postvac. 2 (N=0,55,56,158, 53)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea postvac. 2 (N=0,55,56,158, 53)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting postvac. 2 (N=0,55,56,158, 53)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea postvac. 2 (N=0,55,56,158, 53)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other Reactions postvac. 2 (N=0,55,56,158, 53)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Analgesi/Antipyr Used postvac 2 (N=0,55,56,158,53)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stayed Home postvaccination 2 (N=0,53,0,156,53)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Body Temp &gt; 40 C postvac. 2 (N=0,55,56,158,53)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>All adverse events (AEs) and serious adverse events were collected throughout the duration of the study (day 1 to day 387).</time_frame>
      <desc>Data provided in Other Adverse Events (&gt;5%) were collected. The data included solicited local and systemic reactions that persisted for more than 7 days after each study vaccination. The number of participants at risk is not the same with the numbers provided in the participant flow module as these numbers are analyzed by age and group.</desc>
      <group_list>
        <group group_id="E1">
          <title>2x7.5adj (18 to 64 Yrs)</title>
          <description>A/H1N1 7.5 mcg with MF59; two doses on day 1</description>
        </group>
        <group group_id="E2">
          <title>7.5adj_1_8 (18 to 64 Yrs)</title>
          <description>A/H1N1 7.5 mcg with MF59; one dose on days 1 and 8</description>
        </group>
        <group group_id="E3">
          <title>7.5adj_1_22 (18-64 Yrs)</title>
          <description>A/H1N1 7.5 mcg with MF59; one dose on days 1 and 22</description>
        </group>
        <group group_id="E4">
          <title>15_1_22 (18 to 64 Yrs)</title>
          <description>A/H1N1 15 mcg no MF59; one dose on days 1 and 22</description>
        </group>
        <group group_id="E5">
          <title>2x15_1_22 (18 to 64 Yrs)</title>
          <description>A/H1N1 15 mcg no MF59; two doses on days 1 and 22</description>
        </group>
        <group group_id="E6">
          <title>7.5adj_1_22 (9 to 17 Yrs)</title>
          <description>A/H1N1 7.5 mcg with MF59; one dose on days 1 and 22</description>
        </group>
        <group group_id="E7">
          <title>15_1_22 (9 to 17 Yrs)</title>
          <description>A/H1N1 15 mcg no MF59; one dose on days 1 and 22</description>
        </group>
        <group group_id="E8">
          <title>2x15_1_22 (9 to 17 Yrs)</title>
          <description>A/H1N1 15 mcg no MF59; two doses on days 1 and 22</description>
        </group>
        <group group_id="E9">
          <title>7.5adj_1_22 (3 to &lt;9 Yrs)</title>
          <description>A/H1N1 7.5 mcg with MF59; one dose on days 1 and 22</description>
        </group>
        <group group_id="E10">
          <title>15_1_22 (3 to &lt;9 Yrs)</title>
          <description>A/H1N1 15 mcg no MF59; one dose on days 1 and 22</description>
        </group>
        <group group_id="E11">
          <title>2x15_1_22 (3 to &lt;9 Yrs)</title>
          <description>A/H1N1 15 mcg no MF59; two doses on days 1 and 22</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 17.1</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="159"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Precocious Puberty</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>abdominal pain</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>appendicitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>urinary tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>intervertebral disc protrusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>brain neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>breast cancer</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>abortion threatened</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>high risk pregnancy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>nephrolithiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>uterine haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>sexual abuse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>rhinoplasty</sub_title>
                <description>This AE was reported in the Adults (18 to 64 years of age) under group 2x15_1_22.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>hysterectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>inguinal hernia repair</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 17.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="49" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="41" subjects_at_risk="56"/>
                <counts group_id="E3" subjects_affected="48" subjects_at_risk="56"/>
                <counts group_id="E4" subjects_affected="119" subjects_at_risk="159"/>
                <counts group_id="E5" subjects_affected="35" subjects_at_risk="54"/>
                <counts group_id="E6" subjects_affected="46" subjects_at_risk="53"/>
                <counts group_id="E7" subjects_affected="67" subjects_at_risk="84"/>
                <counts group_id="E8" subjects_affected="43" subjects_at_risk="57"/>
                <counts group_id="E9" subjects_affected="40" subjects_at_risk="55"/>
                <counts group_id="E10" subjects_affected="61" subjects_at_risk="84"/>
                <counts group_id="E11" subjects_affected="41" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>nausea</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="54"/>
                <counts group_id="E2" events="23" subjects_affected="13" subjects_at_risk="56"/>
                <counts group_id="E3" events="17" subjects_affected="11" subjects_at_risk="56"/>
                <counts group_id="E4" events="28" subjects_affected="21" subjects_at_risk="159"/>
                <counts group_id="E5" events="8" subjects_affected="5" subjects_at_risk="54"/>
                <counts group_id="E6" events="6" subjects_affected="6" subjects_at_risk="53"/>
                <counts group_id="E7" events="16" subjects_affected="12" subjects_at_risk="84"/>
                <counts group_id="E8" events="11" subjects_affected="6" subjects_at_risk="57"/>
                <counts group_id="E9" events="10" subjects_affected="8" subjects_at_risk="55"/>
                <counts group_id="E10" events="14" subjects_affected="10" subjects_at_risk="84"/>
                <counts group_id="E11" events="5" subjects_affected="5" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>vomiting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E4" events="5" subjects_affected="3" subjects_at_risk="159"/>
                <counts group_id="E5" events="2" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="84"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="57"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="84"/>
                <counts group_id="E11" events="5" subjects_affected="5" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>diarrhea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E4" events="13" subjects_affected="13" subjects_at_risk="159"/>
                <counts group_id="E5" events="5" subjects_affected="3" subjects_at_risk="54"/>
                <counts group_id="E6" events="4" subjects_affected="4" subjects_at_risk="53"/>
                <counts group_id="E7" events="5" subjects_affected="5" subjects_at_risk="84"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E10" events="3" subjects_affected="3" subjects_at_risk="84"/>
                <counts group_id="E11" events="5" subjects_affected="5" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>injection site erythema</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="54"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E4" events="7" subjects_affected="6" subjects_at_risk="159"/>
                <counts group_id="E5" events="3" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E7" events="4" subjects_affected="4" subjects_at_risk="84"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="57"/>
                <counts group_id="E9" events="4" subjects_affected="3" subjects_at_risk="55"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>injection site pain</sub_title>
                <counts group_id="E1" events="130" subjects_affected="39" subjects_at_risk="54"/>
                <counts group_id="E2" events="79" subjects_affected="31" subjects_at_risk="56"/>
                <counts group_id="E3" events="113" subjects_affected="42" subjects_at_risk="56"/>
                <counts group_id="E4" events="173" subjects_affected="79" subjects_at_risk="159"/>
                <counts group_id="E5" events="108" subjects_affected="23" subjects_at_risk="54"/>
                <counts group_id="E6" events="116" subjects_affected="42" subjects_at_risk="53"/>
                <counts group_id="E7" events="117" subjects_affected="52" subjects_at_risk="84"/>
                <counts group_id="E8" events="160" subjects_affected="37" subjects_at_risk="57"/>
                <counts group_id="E9" events="75" subjects_affected="32" subjects_at_risk="55"/>
                <counts group_id="E10" events="102" subjects_affected="43" subjects_at_risk="84"/>
                <counts group_id="E11" events="116" subjects_affected="29" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>injection site swelling</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="159"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="84"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="57"/>
                <counts group_id="E9" events="3" subjects_affected="3" subjects_at_risk="55"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="84"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>pyrexia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="56"/>
                <counts group_id="E3" events="8" subjects_affected="6" subjects_at_risk="56"/>
                <counts group_id="E4" events="13" subjects_affected="12" subjects_at_risk="159"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E6" events="4" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="84"/>
                <counts group_id="E8" events="8" subjects_affected="6" subjects_at_risk="57"/>
                <counts group_id="E9" events="8" subjects_affected="8" subjects_at_risk="55"/>
                <counts group_id="E10" events="13" subjects_affected="10" subjects_at_risk="84"/>
                <counts group_id="E11" events="12" subjects_affected="10" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>fatigue</sub_title>
                <counts group_id="E1" events="20" subjects_affected="17" subjects_at_risk="54"/>
                <counts group_id="E2" events="34" subjects_affected="20" subjects_at_risk="56"/>
                <counts group_id="E3" events="36" subjects_affected="21" subjects_at_risk="56"/>
                <counts group_id="E4" events="73" subjects_affected="45" subjects_at_risk="159"/>
                <counts group_id="E5" events="30" subjects_affected="18" subjects_at_risk="54"/>
                <counts group_id="E6" events="13" subjects_affected="11" subjects_at_risk="53"/>
                <counts group_id="E7" events="23" subjects_affected="15" subjects_at_risk="84"/>
                <counts group_id="E8" events="26" subjects_affected="14" subjects_at_risk="57"/>
                <counts group_id="E9" events="7" subjects_affected="6" subjects_at_risk="55"/>
                <counts group_id="E10" events="16" subjects_affected="11" subjects_at_risk="84"/>
                <counts group_id="E11" events="9" subjects_affected="6" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>chills</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="54"/>
                <counts group_id="E2" events="11" subjects_affected="9" subjects_at_risk="56"/>
                <counts group_id="E3" events="12" subjects_affected="8" subjects_at_risk="56"/>
                <counts group_id="E4" events="12" subjects_affected="10" subjects_at_risk="159"/>
                <counts group_id="E5" events="14" subjects_affected="11" subjects_at_risk="54"/>
                <counts group_id="E6" events="3" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E7" events="4" subjects_affected="4" subjects_at_risk="84"/>
                <counts group_id="E8" events="5" subjects_affected="4" subjects_at_risk="57"/>
                <counts group_id="E9" events="6" subjects_affected="4" subjects_at_risk="55"/>
                <counts group_id="E10" events="3" subjects_affected="2" subjects_at_risk="84"/>
                <counts group_id="E11" events="3" subjects_affected="2" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>nasopharyngitis</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="54"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="56"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="56"/>
                <counts group_id="E4" events="26" subjects_affected="24" subjects_at_risk="159"/>
                <counts group_id="E5" events="7" subjects_affected="6" subjects_at_risk="54"/>
                <counts group_id="E6" events="7" subjects_affected="7" subjects_at_risk="53"/>
                <counts group_id="E7" events="15" subjects_affected="12" subjects_at_risk="84"/>
                <counts group_id="E8" events="12" subjects_affected="11" subjects_at_risk="57"/>
                <counts group_id="E9" events="6" subjects_affected="4" subjects_at_risk="55"/>
                <counts group_id="E10" events="20" subjects_affected="17" subjects_at_risk="84"/>
                <counts group_id="E11" events="15" subjects_affected="11" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>upper respiratory tract infection</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E3" events="6" subjects_affected="5" subjects_at_risk="56"/>
                <counts group_id="E4" events="7" subjects_affected="6" subjects_at_risk="159"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="84"/>
                <counts group_id="E8" events="3" subjects_affected="3" subjects_at_risk="57"/>
                <counts group_id="E9" events="5" subjects_affected="4" subjects_at_risk="55"/>
                <counts group_id="E10" events="9" subjects_affected="7" subjects_at_risk="84"/>
                <counts group_id="E11" events="7" subjects_affected="6" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>tonsillitis</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E9" events="4" subjects_affected="3" subjects_at_risk="55"/>
                <counts group_id="E10" events="3" subjects_affected="3" subjects_at_risk="84"/>
                <counts group_id="E11" events="6" subjects_affected="6" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>varicella</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="159"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E11" events="3" subjects_affected="3" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>myalgia</sub_title>
                <counts group_id="E1" events="28" subjects_affected="21" subjects_at_risk="54"/>
                <counts group_id="E2" events="25" subjects_affected="17" subjects_at_risk="56"/>
                <counts group_id="E3" events="34" subjects_affected="21" subjects_at_risk="56"/>
                <counts group_id="E4" events="73" subjects_affected="42" subjects_at_risk="159"/>
                <counts group_id="E5" events="22" subjects_affected="17" subjects_at_risk="54"/>
                <counts group_id="E6" events="22" subjects_affected="18" subjects_at_risk="53"/>
                <counts group_id="E7" events="26" subjects_affected="20" subjects_at_risk="84"/>
                <counts group_id="E8" events="22" subjects_affected="14" subjects_at_risk="57"/>
                <counts group_id="E9" events="8" subjects_affected="5" subjects_at_risk="55"/>
                <counts group_id="E10" events="12" subjects_affected="10" subjects_at_risk="84"/>
                <counts group_id="E11" events="13" subjects_affected="9" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>arthralgia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="54"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="56"/>
                <counts group_id="E3" events="14" subjects_affected="10" subjects_at_risk="56"/>
                <counts group_id="E4" events="32" subjects_affected="24" subjects_at_risk="159"/>
                <counts group_id="E5" events="7" subjects_affected="4" subjects_at_risk="54"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E7" events="7" subjects_affected="5" subjects_at_risk="84"/>
                <counts group_id="E8" events="5" subjects_affected="5" subjects_at_risk="57"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E10" events="4" subjects_affected="4" subjects_at_risk="84"/>
                <counts group_id="E11" events="7" subjects_affected="7" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>pain in extremity</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>backpain</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E4" events="3" subjects_affected="2" subjects_at_risk="159"/>
                <counts group_id="E5" events="3" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>headache</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" events="31" subjects_affected="27" subjects_at_risk="54"/>
                <counts group_id="E2" events="49" subjects_affected="21" subjects_at_risk="56"/>
                <counts group_id="E3" events="57" subjects_affected="27" subjects_at_risk="56"/>
                <counts group_id="E4" events="91" subjects_affected="56" subjects_at_risk="159"/>
                <counts group_id="E5" events="30" subjects_affected="17" subjects_at_risk="54"/>
                <counts group_id="E6" events="39" subjects_affected="21" subjects_at_risk="53"/>
                <counts group_id="E7" events="48" subjects_affected="29" subjects_at_risk="84"/>
                <counts group_id="E8" events="22" subjects_affected="11" subjects_at_risk="57"/>
                <counts group_id="E9" events="12" subjects_affected="11" subjects_at_risk="55"/>
                <counts group_id="E10" events="31" subjects_affected="21" subjects_at_risk="84"/>
                <counts group_id="E11" events="15" subjects_affected="11" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>dizziness</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="159"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="54"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="57"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>cough</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="54"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E4" events="9" subjects_affected="8" subjects_at_risk="159"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="54"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E7" events="4" subjects_affected="4" subjects_at_risk="84"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="57"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E10" events="7" subjects_affected="6" subjects_at_risk="84"/>
                <counts group_id="E11" events="5" subjects_affected="4" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Posting Director</name_or_title>
      <organization>Novartis Vaccines and Diagnostics</organization>
      <email>RegContactVacUS.nvdit@Novartis.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

